TARS
Tarsus Pharmaceuticals Inc
74.50$
+2.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 0.7% | 3.6% | 3.7% | 9.1% | 7.0% | 6.8% | |
| – | – | -0.7% | 96.4% | 96.3% | 90.9% | 93.0% | 93.2% | |
| – | – | 56.3% | 73.1% | 165.1% | 288.4% | 29.2% | 14.3% | |
| – | – | 24.4% | 44.5% | 174.1% | 460.4% | 129.7% | 94.7% | |
| – | – | 80.0% | 117.7% | 339.2% | 911.4% | 158.9% | 108.9% | |
| – | – | -80.7% | -21.3% | -242.9% | -820.5% | -65.9% | -15.7% | |
| – | – | 0.6% | 5.1% | 8.0% | 18.5% | 4.1% | 2.0% | |
| – | – | -80.2% | -24.1% | -240.5% | -778.9% | -63.2% | -14.3% | |
| – | – | 0.0% | 0.1% | 0.0% | 4.1% | – | 0.5% | |
| – | – | -80.2% | -24.2% | -240.5% | -778.9% | -63.2% | -14.7% | |
| – | – | -79.5% | -23.6% | -231.3% | -754.7% | -58.2% | -11.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.